Swiss pharmaceutical company Novartis says it is not yet ready to resume production at its facility in Lincoln.
The plant is unlikely to ship over-the-counter drugs before year's end. The company said in a statement Thursday that restarting production is taking longer than expected.
At least one over-the-counter product, Excedrin, started hitting shelves again within the past week, but the company says it is being manufactured at third-party sites.
Novartis shut down the Lincoln plant last December after federal inspections found numerous quality-control problems. Excedrin is one of many products from the Lincoln plant that have been out of stock since the plant shut down. Others include Bufferin, NoDoz, Gas-X, Triaminic, Lamisil and Theraflu.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.